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Abstract 
 
The rationale for the present study was to develop porous CaP/silk composite 
scaffolds with an optimized CaP-phase distribution and pore architecture, to facilitate 
osteogenic properties of human bone mesenchymal stromal cells (BMSCs) and in vivo 
bone formation abilities.  This was achieved by first preparing CaP/silk hybrid 
powders which were then incorporated into silk to obtain uniform CaP/silk composite 
scaffolds, by means of a freeze drying method.  The composition, microstructure and 
mechanical properties of the CaP/silk composite scaffolds were analyzed by X-ray 
diffraction (XRD), Fourier transform infrared spectra (FTIR), scanning electron 
microscope (SEM) and a universal mechanical testing machine.  BMSCs were 
cultured in these scaffolds and cell proliferation analyzed by confocal microscopy and 
MTS assay.  Alkaline phosphatase (ALP) activity and osteogenic gene expression 
were assayed to determine if osteogenic differentiation had taken place.  A calvarial 
defect model in SCID mice was used to determine the in vivo bone forming ability of 
the hybrid CaP/silk scaffolds.  Our results showed that incorporating the hybrid 
CaP/silk powders into silk scaffolds improved both pore structure architecture and 
distribution of CaP powders in the composite scaffolds.  By incorporating the CaP 
phase into silk scaffolds in vitro osteogenic differentiation of BMSCs was enhanced 
and there was increased in vivo cancellous bone formation.  Here we report a novel 
method to prepare Ca/P composite scaffolds with an optimum pore structure and Ca/P 
distribution to facilitate BMSC differentiation and bone formation.  
Introduction 
 
Silk fibroin has been widely trialed in biomaterial studies in the form of silk fibers 
[1-3], membrane [4], microsphere [5] and porous scaffolds [6-9], by virtue of its 
combination of mechanical properties, controllable biodegradability and 
cytocompatibility [10, 11].  As a novel bone tissue engineering material, 
three-dimensional (3D) porous silk scaffolds are receiving more attention because of 
their excellent physiochemical properties [7, 12-14] and much progress has been 
made in understanding how cells interact with silk scaffolds [15, 16].  The 
osteo-conductivity of silk scaffolds has been improved by coating apatite on the 
surface of silk scaffolds using a precipitation method.  The mechanical strength of 
the scaffolds, however, tends to be impaired by this method [17].  Previous studies 
have mainly prepared the 3D silk scaffolds by a salt-leaching method which has 
tended to result in compromised interconnectivity and pore structure [10].  The 
present study therefore sought to develop novel Ca/P composite scaffolds with pore 
structures, interconnectivity, and mechanical properties more suited for bone tissue 
engineering.   
One of most challenging issues when preparing inorganic/organic scaffolds is how to 
uniformly distribute the inorganic powders within the matrix of polymers [18]. 
Inorganic powders have a tendency to aggregate easily due to electrostatic interaction, 
which in turn leads to a suboptimal pore structure and distribution of inorganic 
materials within the scaffolds.  The surface property of the inorganic powders is an 
important factor which influences the powder distribution and pore structure of 
composite scaffolds.  In this study, we first prepared CaP/silk hybrid powders, which 
were then incorporated into silk solution, to fabricate uniform CaP/silk composite 
scaffolds by a freeze drying method.  In the process we developed a new method to 
prepare porous CaP/silk composite scaffolds with potential applications in bone 
regeneration. 
 
2. Materials and Methods 
2.1. Preparation and characterization of CaP/silk hybrid powders 
CaP/silk hybrid powders were prepared using a co-precipitation method.  Typically, 
0.374 g of NaH2PO4·2H2O (Sigma Aldrich, Castle Hill, NSW, Australia) and 2 g of 
silk solution (5 % w/v) was dissolved in 24 mL deionized water and 0.588 g of 
CaCl2·2H2O (Sigma Aldrich) was dissolved in 40 mL ethanol.  Silk protein fibroin 
was extracted from mulberry silk cocoons following a standard extraction procedures 
[19].  The NaH2PO4 and silk water solution was added to CaCl2 ethanol solution 
drop by drop under stirring.  The deposited hybrid powders were filtered, washed 
three times with water and once with ethanol, then vaccum-dried at 40 oC for one day.  
Pure Ca/P powders without silk were prepared under the same preparation conditions 
and used for controls. 
The CaP/silk hybrid powders thus prepared were characterized by X-ray diffraction 
(XRD), scanning electron microscope (SEM) and Fourier transform infrared spectra 
(FTIR).  
2.2. Preparation, characterization and mechanical strength of CaP/silk porous 
composite scaffolds 
Porous silk scaffolds containing CaP/silk hybrid powders were fabricated using a 
freeze-drying method.  Briefly, CaP/silk hybrid powder, at a final concentration of 
either 5 or 10% (w/v), was added into 10 mL of 5% (w/v) silk water solutions under 
stirring to form a uniform mixture.  The mixture was transferred into plastic dishes at 
4ºC for 30 min, and then placed in a freezer at -35ºC overnight to solidify the solvent 
and induce solid–liquid phase separation.  The solidified mixture was maintained at 
-80ºC for 2 hr and was freeze-dried in a freeze-drying vessel (OHRIST BETA 1-15, 
Germany) for 48 hr after which they were treated with 90% (v/v) ethanol.  These 
scaffolds will be referred to as “hybrid CaP/silk” scaffolds.  The silk scaffolds 
containing pure CaP powders were prepared as control by the same method and are 
referred to as “CaP/silk scaffolds”.  Pure silk scaffolds were also prepared for 
controls.  
The pore morphology and microstructure of the top surface, cross section and bottom 
surface of the scaffolds, were characterized by SEM.  
The compressive strength and modulus of the scaffolds (10mm×10mm×10mm) were 
measured using a universal testing machine (Instron) at a crosshead speed of 0.5 
mm/min. 
2.3. Cell morphology and proliferation on CaP/silk scaffolds 
Scaffolds were placed in 96-well plastic culture plates and incubated in Dulbecco’s 
modified Eagle media (DMEM; Invitrogen, Mt Waverley, VIC Australia) overnight.  
The media was aspirated off and then 1x105 BMSCs in a 50 μL suspension volume 
was placed on each scaffold.  The cells were allowed to adhere to the scaffolds for 3 
hr before the cell–scaffold complexes were covered with 150 μL of culture medium 
(DMEM + 10% FBS).  Cell viability and proliferation was determined using 
CellTiter 96 Aqueous One Solution Reagent (Promega, Genesearch. QLD, Australia).  
Briefly, cells were incubated at 37°C in 5% CO2 for 1, 7 and 14 days, at which point 
100 μL of 0.5 mg/mL MTS solution was added to each well and incubated for 4 hr at 
37°C.  Formazan absorbance was read at 490 nm using a plate reader and software 
Accent/MTS.  After 7 day incubation, the scaffolds were fixed in 2.5% 
glutaraldehyde for scanning electron microscope (SEM) and confocal microscopy. 
2.4. Alkaline phosphatase (ALP) activity of BMSCs 
Osteogenic differentiation was assessed by measuring alkaline phosphatase (ALP) 
activity of BMSCs grown on the various scaffold types.  Scaffolds were cut into 
5×5×1 mm pieces and transferred into 24-well plastic culture plates and a total of 
1x105 BMSCs were seeded onto each scaffold.  After 1 day the medium was 
changed to osteogenic differentiation medium (high glucose DMEM containing 10% 
FBS, 50 μM ascorbic acid 2-phosphate, 10 mM β-glycerol phosphate and 100 nM 
dexamethasone (Sigma Aldrich)), which was changed every 4 days.  On days 7 and 
14 samples were removed and ALP activity was measured.  The scaffold were first 
irrigated three times with PBS, to remove as much residual serum as possible, and 
then 1 mL of 0.02% Triton® X-100 were placed on the scaffolds which dissolved the 
cells.  The solution was transferred into a 1.5 mL tube, and sonicated and then the 
samples were centrifuged at 14,000 rpm at 4°C for 15 min, and the supernatant 
transferred to fresh1.5 mL tubes to which 100 µL 1 M Tris-HCl, 20 μL 5 mM MgCl2, 
and 20 μL 5 mM p-nitrophenyl phosphate was added.  After incubation for 30 min at 
37°C the reaction was stopped by the addition of 50 μL of 1N NaOH.  Using 
p-nitrophenol as a standard, the absorbance was measured at 410 nm with a 
spectrophotometer.  The ALP activity was expressed as the value of p-nitrophenol 
production quantity divided by the reaction time and the total protein synthesis 
quantity measured by a BCA Protein assay kit (Thermo Scientific, Melbourne, 
Australia). 
2.5. Reserve transcription and real-time quantitative RT-PCR analysis  
The effect of Ca/P silk scaffolds on BMSC osteogenic differentiation was further 
assessed by real-time quantitative RT-PCR (RT-qPCR) to measure the mRNA 
expression of ALP, type I collagen (COL1) and osteocalcin (OCN) in all treatment 
groups (Table 1).  Scaffolds were cut into 8×8×2 mm pieces and transferred into 
24-well plastic culture plates and a total of 106 BMSCs were placed onto each 
scaffold.  The medium was changed after 24 hours to osteogenic differentiation 
medium.  On day 14 the samples were removed and total RNA isolated using 
Tri-Reagent® (Sigma Aldrich) according to the manufacturer’s instructions.  
Complementary DNA was synthesized from 1 µg of total RNA using SuperScript III 
(Invitrogen) following the manufacturer’s instructions.  RT-qPCR was performed in 
25 µL reaction volume containing 12.5 µL 2X SYBR Green Master Mix (Roche, 
Castle Hill, NSW, Australia), 2.5 µL each of 10 µM forward and reverse primers, 2.5 
µL of cDNA template diluted 1:10, and 5 µL of RNase free water.  All samples were 
performed in triplicates and the house keeping gene, 18s rRNA, was used as a control. 
The reaction was carried out using ABI Prism 7000 Sequence Detection System 
(Applied Biosystems) and the PCR amplification followed 1 cycle of 10 min at 95°C, 
40 cycles of 15 s at 95 and 60°C for 1 min.  Melting curve analysis was performed to 
validate specific amplicon amplification without genomic DNA contamination.  
Relative expression levels for each gene were normalized against the Ct value of the 
house keeping gene and determined by using the delta Ct method.  The relative 
expression of each gene was analysed by one-way ANOVA and 
Student–Newman–Keuls (SNK) q-test. The significant difference was considered at 
P<0.05. 
2.6. Transplantation into calvarial defects 
The bone forming ability of different scaffolds were assessed in a calvarial defect 
model in severe combined immunodeficient (SCID) mice [20].  Pure silk and 5% 
hybrid CaP/silk scaffolds were cut into 3×3×1 mm pieces, transferred into 24-well 
plastic culture plates, and a total of 1x105 BMSCs was seeded on each scaffold.  The 
medium was changed the following day with osteogenic differentiation medium.  
The medium was changed every 4 days and on day 14 the complex was implanted 
into the bone defect. 
The surgeries were carried out according to the guidelines of the Animal Research and 
Care Committee of the Herston Medical Centre and Queensland University of 
Technology.  The surgical procedures were performed in aseptic conditions under 
general anesthesia.  Briefly, a 10 mm linear incision was made on the left side of the 
skull to reveal the bone surface.  The periosteum was dissected from the bone 
surface and a full-thickness calvarial bone defect, 3 mm in diameter, was created with 
a trephine bur with a slow-speed dental drill. To prevent heating injuries to the 
animals, 0.9% physiological saline was dropped onto the contact point between the 
bur and bone and care was taken to avoid injury to the dura of the animals.  The 
implant was trimmed to fit the defect and placed precisely into the defects, and soft 
tissue above the defect was closed with skin staples.  Control sites included calvarial 
defects in which no implants were placed. 
Animals were euthanized 4 weeks after surgery and the defect areas were collected. 
All samples were scanned for bone formation within the defect after implant retrieval 
with a µCT40 imaging system (Scanco Medical, Bassersdorf, Switzerland) with the 
following scan parameters: 20 mm field of view, 55 kVp x-ray energy setting, 1024 
reconstruction matrix, slice thickness 0.02 mm, and a 250 millisecond integration time. 
Mineralized tissue was segmented from non-mineralized tissue using a global 
thresholding procedure with a value approximating 1.20 g/cm3 (150 on μCT) (25% 
lower than 1.6 g/cm3 which is the mineral density of healthy human compact bone. 
Bone volume per defect (BV; mm3) was recorded as the measure of defect bone 
regeneration. 
Following the µCT scan, the samples were fixed in 4% paraformaldehyde for 12 hr at 
room temperature and then decalcified in 10% EDTA, which was changed twice 
weekly, for 2 to 3 weeks before being embedded in paraffin.  Serial sections of 5 µm 
were cut and mounted on polylysine-coated slides, and all sections were stained with 
hematoxylin and eosin for general assessment of the tissue and wound healing. 
Specimens were examined with light microscope. 
2.7. Statistical analysis 
All experiments were performed in triplicate, with each treatment also conducted in 
triplicate.  Means and standard deviations (SD) were calculated, and the statistical 
significance of differences among each group was examined by one-way ANOVA and 
a post hoc t-test.  Significance was set at p<0.05 level. 
3. Results 
3.1. Characterization of CaP/silk hybrid powders and composite scaffolds 
Figure 1 shows the XRD patterns of the pure CaP powders and CaP/silk hybrid 
powders.  The main phase composition for pure CaP powders and CaP/silk hybrid 
powders is monetite (CaPO3(OH)) (JCPD card No: 09-0080).  FTIR analysis 
confirmed the formed CaP/silk hybrid powders by the existence of P-O characteristic 
peaks at the wavenumbers of 562 and 1080cm-1, and silk characteristic peaks at the 
wavemumbers of 1500 and 1600 cm-1 (Fig. 2). SEM analysis showed that the 
prepared CaP/hybrid powders were composed of the lathlike particles with a diameter 
of 500 nm and the sheet-like particles with an approximate size of 3 μm (Fig. 3b). 
Pure CaP powders were composed of irregular particles with an approximate size of 
1-3 μm (Fig. 3a).  
Pure silk and silk composite scaffolds with high porosity were prepared by a 
freeze-drying method.  Pore structure and distribution was analyzed in the top 
surface and inner microstructures of pure silk scaffolds and composite scaffolds.  
This analysis revealed that pore structure and distribution was more uniform in 
hybrid-CaP/silk scaffolds than in CaP/silk scaffolds (Fig. 4). The bottom surface of 
the scaffolds showed no obvious aggregation of CaP powders in the hybrid CaP/silk 
scaffolds (Fig. 5b and c), whereas CaP powders in CaP/silk scaffolds became 
aggregated (see arrows) (Fig. 5d and e).  The incorporation 5% and 10% of CaP 
powders into silk scaffolds did not influence the compressive strength and 
compressive modulus of the scaffolds (Fig. 6). 
After having established that hybrid CaP/silk scaffolds had improved pore structure 
and powder distribution compared to the CaP/silk scaffolds, our focus shifted to the 
hybrid scaffolds for the subsequent experiments, which included mechanical testing, 
BMSCs attachment, proliferation, differentiation and in vivo experiments.  
3.2. BMSCs morphology, proliferation and ALP activity 
After 1 day of culture, BMSCs were found to have attached and were distributed even 
to the inner of scaffolds with a spread out morphology (Fig. 6 a, d, g). After seven 
days the number of cells had increased significantly in all three types of scaffolds.  
There was no noticeable structural or cell number difference among the three types of 
scaffolds (Fig. 7 b, e, h), and confocal microscopy images showed that cells were 
uniformly distributed within the scaffolds (Fig. 7 c, f, i).  
There was a clear temporal proliferation profile of the BMSCs after 1, 7 and 14 
days of culture on all three scaffold species (Fig. 8a), but no obvious proliferation 
differences between scaffold species (Fig. 8a).  
All three scaffold species supported BMSCs differentiation and the 5% and 10% 
hybrid CaP/silk scaffolds showed a significantly higher ALP activity level after 7 and 
14 days of culture compared to pure silk scaffolds (Fig. 8b).  There was, however, no 
obvious difference between the 5% and 10% hybrid CaP/silk scaffolds.  
3.3. Real time quantitative RT-PCR 
The osteoblastic differentiation was further assessed by RT-qPCR of ALP, COL1 and 
OCN mRNA expression.  There was a significant upregulation of the osteogenic 
marker genes ALP, COL1 and OCN in the BMSCs after 2 weeks in osteogenic 
culture media in the hybrid CaP/silk scaffolds compared to those in pure silk scaffolds 
(Fig. 9).  
3.4 In vivo study 
Quantification of the mineralized areas in skull bone defects showed only low levels 
of calcified tissue in either the unfilled defects or defects filled with pure silk 
scaffolds only (Fig 10). There was a significant increase of calcified tissues in the 
defects filled with CaP/silk scaffold compared to both unfilled defects and defects 
filled with pure silk scaffolds.  Interestingly, incorporation of BMSCs with hybrid 
CaP/silk scaffolds induced the most significant tissue calcification in bone defects  
(p < 0.05).    
There was no histological evidence of an inflammatory reaction in any of the 
treatment groups four weeks after implantation (Fig. 11).  Histological analysis 
confirmed the bone formation that was observed in the micro-CT scans.  Unfilled 
calvarial defects were covered with a thin fibrous connective tissue sheet with no 
evidence of new bone formation.  Bone defects filled with silk fibroin scaffold alone 
showed increased amounts of cells and fibrous tissue within the defects, however, no 
new bone was observed. New bone formation was found in defects filled with 
Cap/silk scaffold, silk and hybrid CaP/silk scaffolds seeded with BMSCs.  In pure 
silk scaffolds seeded with BMSCs, newly formed bone was only formed in areas 
adjacent to the rim of the defects.  In defects filled with CaP/silk scaffolds (both 
CaP/silk and hybrid CaP/silk), with and without BMSCs, bone islands were identified 
both peripherally and centrally within the scaffolds.  In addition to this, mineralized 
bony trabeculae were also found and these were surrounded by osteoblasts.  
 
4. Discussion 
In this study we incorporated hybrid CaP/silk powders into silk scaffolds to improve 
the pore structure, architecture and distribution of CaP powders in the composite 
scaffolds.  This approach resulted in enhanced in vitro osteogenic differentiation of 
BMSCs and new bone formation scattered inside the scaffolds in a skull bone defect 
model. 
Inorganic/organic scaffolds have traditionally been prepared by direct incorporation of 
inorganic powders into polymer materials.  Distributing the inorganic powders 
uniformly throughout the matrix of polymers is the greatest challenge associated with 
this method, primarily due to aggregation of the powders and incompatible surface 
properties between the inorganic materials and polymers [21, 22]. In this study, we 
have applied a novel method to produce a hybrid of CaP/silk powders by the 
co-precipitation of CaP particles and silk.  The hybrid CaP/silk powders had an 
improved interface compatibility with the silk scaffolds as well as improved of CaP 
distribution within the silk scaffolds, which was reflected in significantly less 
aggregation of CaP particles on the silk surfaces.  
CaP/silk scaffolds can be prepared by coating a layer of CaP on the surface of a silk 
scaffold using a precipitation methods [17], in which the silk scaffolds is first 
prepared by a salt-leaching method.  Although the CaP/silk composite scaffolds 
produced by this method have improved osteoconductive properties, these composite 
scaffolds do not have interconnecting pores, and the mechanical strength of the 
scaffolds is weakened when covered with CaP particles.  In the method we applied, 
hybrid-CaP/silk powders were incorporated into silk scaffolds by freeze-drying.  The 
scaffolds produced this way had far better interconnectivty and an uniform 
distribution of CaP particles, and this was achieved without compromising the 
mechanical strength of the scaffolds[17]. 
Scaffolds porosity is important for aiding cell functions, by providing a foundation for 
cell attachment, proliferation, and cell matrix formation [23, 24].  The porous 
CaP/silk scaffolds appeared to provide a good environment for BMSC growth and 
differentiation.  There was a near 4-fold increase in the number of cells on the 
CaP/silk scaffold after two weeks of culture, and in the presence of osteogenic media 
BMSCs showed increased expression levels of osteogenic markers. It seems quite 
possible the influence of CaP particles on BMSC differentiation is the reason for the 
better osteogenic differentiation properties of the CaP/silk scaffold compared with the 
pure silk scaffolds alone.  Calcium phosphate containing materials, when hydrated in 
cell culture media, undergo a process of continuous calcium and phosphate ion 
dissolution and reprecipitation, and this process can induce osteoblast differentiation 
and mineralization [23]. Furthermore, CaP particles are known to enhance the healing 
of bone defect by stimulating osteoblast differentiation [25].  
The fundamental premise of tissue engineering is regeneration of tissues and 
restoration of organ function through implantation of cells grown outside the body or 
by stimulating cells to migrate into an implanted matrix. [26]  The clinical success of 
the construct depends to a large degree on the quality of the scaffold and supplied 
cells.  It is our view that the material we have developed may be used to accelerate 
new bone formation in bone defects.  The in vivo study showed that pure silk 
scaffolds did not induce any bone formation, in spite of these materials having an 
excellent pore structure.  The hybrid CaP/silk scaffolds, on the other hand, with a 
pore structure similar to that of pure silk scaffolds, did induce bone formation.  Also, 
the amount of bone induced by BMSCs seeded on hybrid CaP/silk scaffolds was 
significantly greater than the amount of bone induced by BMSCs on silk scaffolds.  
There are a couple of likely factors contributing to this improved bone forming ability: 
firstly, the hybrid CaP/silk scaffolds had a more uniform distribution of CaP particles 
which had the effect of enhancing bone cell differentiation and further improved bone 
formation after implantation into the bone defects.  The second reason is that the 
hybrid CaP/silk scaffolds had a more interconnected and larger pore structure, and this 
was beneficial for cell ingrowth and nutrient supply and providing a more optimum 
environment for new bone formation.  
 
5. Conclusions 
Our results demonstrated that incorporation of hybrid CaP/silk powders into silk 
scaffolds improved the porous structure and distribution of CaP powders in the 
composite scaffolds, which enhanced in vitro BMSCs osteogenic differentiation, and 
also improved in vivo bone formation.  This study proposed a novel method to 
fabricate hybrid CaP/silk scaffolds for potential cell based therapy in bone defect 
repair. 
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